SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-23-192733
Filing Date
2023-07-25
Accepted
2023-07-25 07:04:31
Documents
4
Group Members
DURNING ACQUISITION CORP

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d465121dsctota.htm SC TO-T/A 24729
2 EX-99.(A)(5)(B) d465121dex99a5b.htm EX-99.(A)(5)(B) 12893
3 GRAPHIC g465121dsp6.jpg GRAPHIC 10517
4 GRAPHIC g465121dsp6a.jpg GRAPHIC 11386
  Complete submission text file 0001193125-23-192733.txt   59235
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Subject) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC TO-T/A | Act: 34 | File No.: 005-92879 | Film No.: 231106438
SIC: 2834 Pharmaceutical Preparations